British genomics interpretation software vendor Congenica will help researchers analyze WGS and WES in search of a genetic cause for sudden unexpected death in epilepsy.
The UK-based maker of clinical genomics interpretation software is moving into the US and China after carefully researching the differences from European markets.
British software firm Congenica is partnering with Hong Kong's Digital China Health Technologies to expand its clinical genomics interpretation business in China.
Irish rare disease research center FutureNeuro is partnering with software vendor Congenica to bring sequencing to the point of care for genetic epilepsies.
As of this week, the project had sequenced 39,500 genomes and returned reports for about 3,000 rare disease families and more than 600 cancer patients.
British genomics interpretation software vendor Congenica inked a deal with a Portuguese hospital to analyze whole-exome sequencing data for the In2Genome project.
UniteGen will use the Sapientia clinical genome analysis software platform as part of a large-scale genomics project in China.
The companies are bundling their software and hardware with the goal of accelerating "DNA-to-diagnosis" time in clinical settings
Congenica will use the proceeds to establish its presence in the US and China, where it will court not only clinical genetics labs, but specialists, academics, biotech, and pharma.
The company will use the proceeds from the round to invest in sales and marketing efforts for its Sapientia clinical genome analysis platform, as well as for R&D.
Oil made from gene-edited soybeans is already in use, according to the Associated Press.
USA Today reports that Department of Veterans Affairs is teaming up with Sanford Health to provide veterans with genetic testing.
Mother Jones reports there are few regulations overseeing the use of genetic genealogy by law enforcement.
In Science this week: analysis of ancient DNA recovered from Iberian populations, and more.